Parataxis Korea, Inc. (KOSDAQ: A288330)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
Parataxis Korea, Inc. (KOSDAQ: A288330) operates in the Biotechnology industry within the Health Care sector. The company is valued at $29.36M.
trading between 392.00 and 9.28K.
Tweenvest scores Parataxis Korea, Inc. across four factors: quality 32/100, value 22/100, growth 0/100. Its strongest factor is quality.
A288330 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $29.36M
- Revenue (TTM)
- $1.03M
- P/E
- —
- EPS
- -424.80
- Dividend yield
- —
- Beta (5Y)
- 1.68
- 52-week high
- ₩9,280.00
- 52-week low
- ₩392.00
- Avg volume (3M)
- —
- Shares outstanding
- 106.08M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BriaCell Therapeutics Corp.TSX: BCT | $30.01M | CA$4.88 | -13.01% |
| Poltreg S.A.WSE: PTG | $29.79M | zł19.55 | +0.26% |
| Nicox S.A.ENXTPA: ALCOX | $29.74M | €0.30 | -2.91% |
| Cleo Diagnostics LtdASX: COV | $29.57M | AU$0.31 | -1.59% |
| Medicenna Therapeutics Corp.TSX: MDNA | $29.36M | CA$0.45 | +3.45% |
| Quratis Inc.KOSDAQ: A348080 | $29.12M | ₩3,310.00 | -11.50% |
| Microbix Biosystems Inc.TSX: MBX | $29.05M | CA$0.30 | -3.23% |
| CEL-SCI CorporationNYSEAM: CVM | $28.85M | $1.64 | +1.86% |
Figures last refreshed Oct 18, 2026.